Cover Image
Market Research Report

Global Transcatheter Market Research Report: By Type of Treatment (Transfemoral Approach, Transapical Approach, and Others), by Product Type (TAVR and TMVR), by End-User (Hospitals, Ambulatory Surgical Centers, Others), and by Region-Forecast Till 2023

Published by Market Research Future Product code 792012
Published Content info 100 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Transcatheter Market Research Report: By Type of Treatment (Transfemoral Approach, Transapical Approach, and Others), by Product Type (TAVR and TMVR), by End-User (Hospitals, Ambulatory Surgical Centers, Others), and by Region-Forecast Till 2023
Published: January 31, 2019 Content info: 100 Pages
Description

Introduction

Transcatheter is a minimally invasive procedure which is used to replace the valve in patients with cardiac stenosis without removing the old or damaged valve. Transcatheter is further segmented into two types, namely, transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve replacement (TMVR). The growth of this market is majorly due to the high prevalence of cardiovascular diseases, the rise in mitral valve disorders, and technological advancements coupled with the introduction of novel cardiac valves. According to the World Health Organization (WHO), in 2015, over 17.7 million people died from cardiovascular diseases, representing 31% of all the global deaths. Despite the drivers, the high cost of surgeries and stringent government regulations may hamper the growth of this market.

The global transcatheter market is expected to reach a market value of USD 3,882.77 million by 2023 from USD 8,191.26 million in 2017 and is expected to register a CAGR of 13.38% during the forecast period from 2018 to 2023. In 2017, the market was led by the Americas with a 35.1% share, followed by Europe and Asia-Pacific with shares of 30.9% and 27.0%, respectively. The increasing burden of cardiovascular diseases has been observed in different parts of the world which has upsurge the growth of the market.

The global transcatheter market is segmented by type of treatment, product type, end user, and region.

The global transcatheter market, by type of treatment, is segmented into transfemoral approach, transapical approach, and transaortic approach.

The global transcatheter market, by product type, is segmented into transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR).

By end user, the global transcatheter market is segmented into hospitals, ambulatory surgical centers (ASCs), and cardiac catheterization laboratory.

Key Players

Edward Lifesciences Corporation, Meril Life Sciences Pvt. Ltd, Braile Biomedica, Venus Medtech, Boston Scientific Corporation, JenaValve Technology, Inc., Abbott Laboratories, Medtronic Plc, Bracco Diagnostic Inc., Cook Medical Inc., and others.

Study Objectives

  • To provide a comprehensive analysis of the transcatheter industry and its sub-segments in the global market, thereby providing a detailed structure of the industry
  • To provide detailed insights into factors driving and restraining the growth of the global transcatheter market
  • To estimate the market size of the global transcatheter market from 2015 to 2023 for different regions. Wherein, 2015 and 2016 would be the historic period, 2017 shall be the base year, and 2018 to 2023 would be the forecast period for the study
  • To analyze the global transcatheter market, on the basis of four main geographies, namely, the Americas, Europe, Asia-Pacific, and the Middle East and Africa
  • To compare the products with respect to various players in the market
  • To provide country-wise market value analysis for various segments of the transcatheter market
  • To provide strategic profiling of key companies (manufacturers and distributors) present across the globe and comprehensively analyze their competitiveness/competitive landscape in this market
  • To provide distribution chain analysis/value chain for the transcatheter market

Target Audience

  • Medical Device Manufacturers
  • Medical Device Suppliers & Distributors
  • Research and Development (R&D) Companies
  • Government Research Institutes
  • Academic Institutes and Universities

Key Findings

  • The global transcatheter market is expected to reach USD 3,882.77 million by 2023 from USD8,191.26 million in 2017 and is expected to register a CAGR of 13.38% during the forecast period from 2018 to 2023.
  • On the basis of type of treatment, the transfemoral approach segment accounted for the largest market share and is projected to register the CAGR of 13.2% by 2023
  • Based on product type, the transcatheter aortic valve replacement (TAVR) segment accounted for the largest market share and is anticipated to register a CAGR of 13.1% by 2023
  • Based on end user, the hospitals segment held the largest market share of 41.3% in 2017 and is projected to register a CAGR of 13.1% during the forecast period
  • The Americas is expected to hold the largest share of the global transcatheter market at a CAGR of 12.5% by 2023
  • Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 14.0% by 2023

Regional Analysis

  • Americas
    • North America
  • US
  • Canada
    • Latin America
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Republic of Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • Middle East
    • Africa
Table of Contents

Table of Contents

1 Executive Summary

2 Market Introduction

  • 2.1 Scope of the Study
  • 2.2 Research Objective
  • 2.3 List of Assumptions
  • 2.4 Market Structure

3 Research Methodology

  • 3.1 Research Process
  • 3.2 Primary Research
  • 3.3 Secondary Research
  • 3.4 Market Size Estimation
  • 3.5 Forecast Model

4 Market Dynamics

  • 4.1 Drivers
    • 4.1.1 Introduction
    • 4.1.2 Increase in preference for minimally invasive procedures
    • 4.1.3 Increasing prevalence of cardiovascular diseases
    • 4.1.4 Favorable reimbursement policies
  • 4.2 Restraints
    • 4.2.1 Strict regulatory guidelines
    • 4.2.2 Risk of infection
  • 4.3 Opportunities
    • 4.3.1 New advancements in novel cardiac catheterization devices

5 Market Factor Analysis

  • 5.1 Value Chain Analysis
    • 5.1.1 R&D and Designing
    • 5.1.2 Manufacturing
    • 5.1.3 Distribution & Sales
    • 5.1.4 Post-sales Monitoring
  • 5.2 Porter's Five Forces Model
    • 5.2.1 Bargaining power of suppliers
    • 5.2.2 Bargaining power of buyers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitutes
    • 5.2.5 Intensity of Rivalry
  • 5.3 Demand & Supply: Gap Analysis
  • 5.4 Pricing Analysis

6 Global Transcatheter Market, By Type of Treatment

  • 6.1 Overview
    • 6.1.1 Transfemoral Approach
    • 6.1.2 Transapical Approach
    • 6.1.3 Transaortic Approach

7 Global Transcatheter Market, By Product Type

  • 7.1 Introduction
    • 7.1.1 Transcatheter Aortic Valve Replacement (TAVR)
    • 7.1.2 Transcatheter Mitral Valve Repair (TMVR)

8 Global Transcatheter Market, By End User

  • 8.1 Introduction
    • 8.1.1 Hospitals
    • 8.1.2 Ambulatory Surgical Centres (ASCs)
    • 8.1.3 Cardiac Catheterization Laboratory

9 Global Transcatheter Market, By Region

  • 9.1 Introduction
  • 9.2 Americas
    • 9.2.1 North America
      • 9.2.1.1 U.S.
      • 9.2.1.2 Canada
    • 9.2.2 South America
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 U.K
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 Rest of Asia Pacific
  • 9.5 Middle East & Africa
    • 9.5.1 Middle East
    • 9.5.2 Africa

10 Company Landscape

  • 10.1 Company Market Share Analysis
    • 10.1.1 Introduction
  • 10.2 Competitive Landscape
    • 10.2.1 Introduction
  • 10.3 Key Developments

11 Company Profiles

  • 11.1 Edwards Lifesciences Corporation
    • 11.1.1 Company Overview
    • 11.1.2 Financial Overview
    • 11.1.3 Products Offering
    • 11.1.4 Key Developments
    • 11.1.5 SWOT Analysis
    • 11.1.6 1.1.6 Key Strategy
  • 11.2 Meril Life Sciences Pvt. Ltd.
    • 11.2.1 1.2.1 Company Overview
    • 11.2.2 Financial Overview
    • 11.2.3 Products Offering
    • 11.2.4 Key Developments
    • 11.2.5 1.2.5 SWOT Analysis
    • 11.2.6 Key Strategy
  • 11.3 Braile Biomedica
    • 11.3.1 1.3.1 Company Overview
    • 11.3.2 Financial Overview
    • 11.3.3 Products Offering
    • 11.3.4 Key Developments
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Strategy
  • 11.4 Venus Medtech
    • 11.4.1 1.4.1 Company Overview
    • 11.4.2 Financial Overview
    • 11.4.3 Products Offering
    • 11.4.4 Key Developments
    • 11.4.5 Key Strategy
  • 11.5 Boston Scientific Corporation
    • 11.5.1 Company Overview
    • 11.5.2 Financial Overview
    • 11.5.3 Products Offering
    • 11.5.4 Key Developments
    • 11.5.5 Key Strategy
  • 11.6 JenaValve Technology, Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Financial Overview
    • 11.6.3 Products Offering
    • 11.6.4 Key Developments
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Strategy
  • 11.7 Abbott Laboratories
    • 11.7.1 Company Overview
    • 11.7.2 Financial Overview
    • 11.7.3 Products Offering
    • 11.7.4 Key Developments
    • 11.7.5 SWOT Analysis
    • 11.7.6 1.7.6 Key Strategy
  • 11.8 Medtronic PLC
    • 11.8.1 Company Overview
    • 11.8.2 Financial Overview
    • 11.8.3 Products Offering
    • 11.8.4 Key Developments
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Strategy
  • 11.9 Bracco Diagnostic Inc.
    • 11.9.1 Company Overview
    • 11.9.2 Financial Overview
    • 11.9.3 Products Offering
    • 11.9.4 Key Developments
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Strategy
  • 11.1 Cook Medical Inc.
    • 11.10.1 Company Overview
    • 11.10.2 Financial Overview:
    • 11.10.3 Products Offering
    • 11.10.4 Key Developments
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key strategy

12 Appendix

  • 12.1 Discussion Blue Print
  • 12.2 Reference

List of Tables

  • TABLE 1 MARKET SYNOPSIS
  • TABLE 2 LIST OF ASSUMPTIONS
  • TABLE 3 PRIMARY INTERVIEWS
  • TABLE 4 GLOBAL TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 5 GLOBAL TRANSCATHETERSS MARKET FOR TRANSFEMORAL APPROACH, BY REGION 2015-2023 (USD MILLION)
  • TABLE 6 GLOBAL TRANSCATHETERSS MARKET FOR TRANSAPICAL APPROACH, BY REGION 2015-2023 (USD MILLION)
  • TABLE 7 GLOBAL TRANSCATHETERSS MARKET FOR TRANSAORTIC APPROACH, BY REGION 2015-2023 (USD MILLION)
  • TABLE 8 GLOBAL TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 9 GLOBAL TRANSCATHETERSS MARKET FOR TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR), BY REGION 2015-2023 (USD MILLION)
  • TABLE 10 GLOBAL TRANSCATHETERSS MARKET FOR TRANSCATHETER MITRAL VALVE REPAIR (TMVR), BY REGION 2015-2023 (USD MILLION)
  • TABLE 11 GLOBAL TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 12 GLOBAL TRANSCATHETERSS MARKET FOR HOSPITALS, BY REGION 2015-2023 (USD MILLION)
  • TABLE 13 GLOBAL TRANSCATHETERSS MARKET FOR AMBULATORY SURGICAL CENTERS (ASCS), BY REGION 2015-2023 (USD MILLION)
  • TABLE 14 GLOBAL TRANSCATHETERSS MARKET FOR CARDIAC CATHETERIZATION LABORATORY, BY REGION 2015-2023 (USD MILLION)
  • TABLE 15 GLOBAL TRANSCATHETER MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 16 AMERICAS TRANSCATHETER MARKET, BY REGION 2015-2023 (USD MILLION)
  • TABLE 17 NORTH AMERICA TRANSCATHETER MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 18 NORTH AMERICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 19 NORTH AMERICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 20 NORTH AMERICA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 21 U.S. TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 22 U.S. TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 23 U.S. TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 24 CANADA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 25 CANADA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 26 CANADA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 27 SOUTH AMERICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 28 SOUTH AMERICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 29 SOUTH AMERICA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 30 EUROPE TRANSCATHETER MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 31 EUROPE TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 32 EUROPE TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 33 EUROPE TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 34 GERMANY TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 35 GERMANY TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 36 GERMANY TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 37 U.K TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 38 U.K TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 39 U.K TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 40 FRANCE TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 41 FRANCE TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 42 FRANCE TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 43 SPAIN TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 44 SPAIN TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 45 SPAIN TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 46 ITALY TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 47 ITALY TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 48 ITALY TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 49 REST OF EUROPE TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 50 REST OF EUROPE TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 51 REST OF EUROPE TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 52 ASIA PACFIC TRANSCATHETER MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 53 ASIA PACIFIC TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 54 ASIA PACIFIC TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 55 ASIA PACIFIC TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 56 CHINA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 57 CHINA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 58 CHINA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 59 JAPAN TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 60 JAPAN TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 61 JAPAN TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 62 INDIA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 63 INDIA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 64 INDIA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 65 AUSTRALIA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 66 AUSTRALIA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 67 AUSTRALIA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 68 REST OF ASIA PACIFIC TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 69 REST OF ASIA PACIFIC TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 70 REST OF ASIA PACIFIC TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 71 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY COUNTRY 2015-2023 (USD MILLION)
  • TABLE 72 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 73 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 74 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 75 MIDDLE EAST TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 76 MIDDLE EAST TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 77 MIDDLE EAST TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 78 AFRICA TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2015-2023 (USD MILLION)
  • TABLE 79 AFRICA TRANSCATHETER MARKET, BY PRODUCT TYPE 2015-2023 (USD MILLION)
  • TABLE 80 AFRICA TRANSCATHETER MARKET, BY END USER 2015-2023 (USD MILLION)
  • TABLE 81 GLOBAL TRANSCATHETERS MARKET: KEY DEVELOPMENT

List of Figures

  • FIGURE 1 GLOBAL TRANSCATHETER MARKET: MARKET STRUCTURE
  • FIGURE 2 RESEARCH PROCESS
  • FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
  • FIGURE 4 VALUE CHAIN: TRANSCATHETER MARKET
  • FIGURE 5 PORTERS FIVE FORCES MODEL
  • FIGURE 6 GLOBAL TRANSCATHETER MARKET, BY TYPE OF TREATMENT 2017 & 2023 (USD MILLION)
  • FIGURE 7 GLOBAL TRANSCATHETER MARKET, BY PRODUCT TYPE 2017 & 2023 (USD MILLION)
  • FIGURE 8 GLOBAL TRANSCATHETER MARKET, BY END USER 2017 & 2023 (USD MILLION)
  • FIGURE 9 GLOBAL TRANSCATHETER MARKET, BY REGION 2017 & 2023 (USD MILLION)
  • FIGURE 10 AMERICAS TRANSCATHETER MARKET, BY REGION 2017 (%)
  • FIGURE 11 NORTH AMERICA TRANSCATHETER MARKET, BY COUNTRY 2017 (%)
  • FIGURE 12 EUROPE TRANSCATHETER MARKET, BY COUNTRY 2017 (%)
  • FIGURE 13 ASIA PACFIC TRANSCATHETER MARKET, BY COUNTRY 2017 & 2023 (%)
  • FIGURE 14 MIDDLE EAST & AFRICA TRANSCATHETER MARKET, BY COUNTRY 2017 & 2023 (%)
  • FIGURE 15 GLOBAL TRANSCATHETERS MARKET, MARKET SHARE ANALYSIS 2017 (%)
  • FIGURE 16 GLOBAL TRANSCATHETERS MARKET COMPETITIVE LANDSCAPE (%)
Back to Top